The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes.

Breast Cancer Research and Treatment
Maryam AlthobitiEmad Rakha

Abstract

BMI1, which is a major component of the polycomb group complex 1, is an essential epigenetic repressor of multiple regulatory genes and has been identified as a cancer stem cell (CSC) marker in several cancers. However, its role in breast cancer (BC) remains to be defined. In this study, we have evaluated the prognostic significance of BMI1 among the different molecular subtypes and assessed its association with other breast CSC markers (BCSC). BMI1 copy number and mRNA was assessed in large and well-characterised cohorts of early-stage BC patients [METABRIC (n = 1980) and the Bc-GenExMiner (n = 9616) databases]. BMI1 protein expression was assessed using tissue microarray and immunohistochemistry in a cohort of 870 invasive BC patients with long-term outcome data and the expression of a panel of BCSC markers was monitored. BMI1 expression, prognostic significance and its association with BCSC markers were differed between molecular classes. In the luminal oestrogen receptor-positive (ER+) BC, BMI1 showed significantly higher expression compared to ER- tumours. BMI1 showed positive correlation with favourable prognostic features and it was negatively associated with the expression of key BCSC markers (ALDH1A1, CD24, CD44, CD133...Continue Reading

References

Sep 30, 2004·The Breast : Official Journal of the European Society of Mastology·Joo Heon KimJae Wha Kim
Jan 30, 2008·Breast Cancer Research and Treatment·Young Jin ChoiSeok Jin Nam
Apr 1, 2011·Breast Cancer Research and Treatment·Pascal JézéquelLoïc Campion
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Oct 18, 2011·Breast Cancer Research and Treatment·Ayodeji J AgboolaAndrew R Green
Nov 29, 2011·Breast Cancer Research and Treatment·Mohamed A H AhmedIan O Ellis
Dec 15, 2012·The Journal of Biological Chemistry·Joon-Ho ChoGoberdhan P Dimri
Dec 10, 2014·Journal of Clinical Pathology·Emad A RakhaUNKNOWN National Coordinating Committee for Breast Pathology
Feb 11, 2015·Breast Cancer Research and Treatment·Su-Hyeong Kim, Shivendra V Singh
Oct 9, 2015·Genes & Diseases·Resham BhattacharyaShailendra Kumar Dhar Dwivedi
Dec 2, 2015·Oncology Letters·Min-Cong WangKe-Jun Nan
Aug 23, 2017·British Journal of Cancer·Mohammed A AleskandaranyEmad A Rakha
Nov 2, 2019·Life Sciences·Indrė Januškevičienė, Vilma Petrikaitė

❮ Previous
Next ❯

Software Mentioned

tile Bioinformatics
SPSS
METABRIC
tile

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Shin-ichi YamashitaShuji Suehiro
Ai zheng = Aizheng = Chinese journal of cancer
Yan FengLing Zhang
© 2022 Meta ULC. All rights reserved